Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06358001 · ClinicalTrials.gov registry record
EchoTip AcuCore Post-Market Clinical Study
A clinical trial of Hepatocellular Carcinoma and Cholangiocarcinoma, sponsored by Cook Research Incorporated.
- Completed
- Registry status
- 183
- Enrollment target
- 8
- Study locations
NCT06358001 is a study of Hepatocellular Carcinoma and Cholangiocarcinoma that has completed, run by Cook Research Incorporated. The registered enrollment target is 183 participants, below the 256-participant average among 145 other Hepatocellular Carcinoma trials with a reported enrollment target (29% lower). The trial reports 8 study locations across 6 states.
The verdict
NCT06358001, a study of Hepatocellular Carcinoma and Cholangiocarcinoma, has completed, sponsored by Cook Research Incorporated.
- COMPLETED
- Registry status
- 183 participants
- Enrollment target
- 8
- Study locations
Study Summary
The purpose of collecting this data is to continue to learn more about the EchoTip AcuCore and the device's ability to produce the desired favorable effect and if there are any undesired outcomes that may be related to the EchoTip AcuCore.
Conditions Studied
Interventions
- DEVICE EchoTip AcuCore
Study Locations (8)
Florida
- Shands Hospital-University of Florida - Gainesville
- University of Florida Shands Hospital - Gainesville
- Advent Health Medical Group, Orlando - Orlando
California
- University of California, Irvine - Orange
Colorado
- Advent Health, Porter - Denver
Pennsylvania
- Geisinger Medical Center - Danville
Texas
- University of Texas Memorial Hermann Hospital - Houston
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 183 participants |
| Start Date | 2024-08-05 |
| Est. Completion | 2025-07-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06358001
The ClinicalTrials.gov registry entry for NCT06358001 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 183 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 256-participant average among 145 other Hepatocellular Carcinoma trials with a reported enrollment target (29% lower). The listed sponsor is Cook Research Incorporated, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 8 conditions, with Hepatocellular Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which EchoTip AcuCore is the first listed.
NCT06358001 reports 8 study locations spanning 6 distinct geographic areas - top geographies include Florida, California, Colorado.
Frequently Asked Questions
What is clinical trial NCT06358001 about?
NCT06358001 is a clinical study titled "EchoTip AcuCore Post-Market Clinical Study". The purpose of collecting this data is to continue to learn more about the EchoTip AcuCore and the device's ability to produce the desired favorable effect and if there are any undesired outcomes that may be related to the EchoTip AcuCore.
What is the current status of trial NCT06358001?
This trial is currently completed. The enrollment target is 183 participants. The study started on 2024-08-05. Estimated completion is 2025-07-19.
What conditions does trial NCT06358001 study?
This clinical trial studies the following conditions: Hepatocellular Carcinoma, Cholangiocarcinoma, Neuroendocrine Tumors, Chronic Pancreatitis, Adenocarcinoma.
What interventions are being tested in trial NCT06358001?
The interventions under investigation include: EchoTip AcuCore (DEVICE).
Who is sponsoring clinical trial NCT06358001?
This trial is sponsored by Cook Research Incorporated, which has 24 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06358001 being conducted?
This trial has 8 study locations across California, Colorado, Florida, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatocellular Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Molecular Basis of Pediatric Liver Cancer
RECRUITING
-
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
RECRUITING · Phase 2
-
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RECRUITING · Phase 1
-
Targeted Navigation in Hepatocellular Carcinoma (HCC)
RECRUITING · NA
-
Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
RECRUITING · Phase 1
-
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.